Details for Patent: 4,448,774
✉ Email this page to a colleague
Summary for Patent: 4,448,774
Title: | Steroid formulation |
Abstract: | There is described an aqueous pharmaceutical solution comprising a steroid selected from prednisolone, prednisolone sodium phosphate, prednisone and methyl prednisolone, the steroid being present at a concentration of at least 0.3 mg/ml., the pH of the formulation between 5 and 8 and the formulation containing a pharmaceutically acceptable preservative, a pharmaceutically acceptable chelating agent, and being substantially free of ethanol. There is also described a method of treatment of a variety of conditions, particularly in children, using the solution. |
Inventor(s): | Clemente; Emmett (Manchester, MA), Fung; Ho-Leung (Getzville, NY), Brousseau; Denise (Andover, MA) |
Assignee: | Fisons Corporation (Bedford, MA) |
Application Number: | 06/452,294 |
Patent Claim Types: see list of patent claims | Formulation; Compound; Dosage form; Use; |
Drugs Protected by US Patent 4,448,774
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |